Literature DB >> 25342222

The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome.

Ramona Moldovan1, Sianan Keating, Tara Clancy.   

Abstract

Women with Lynch syndrome (LS) have a significantly increased lifetime risk of endometrial cancer (40-60 %) and ovarian cancer (7-12 %). Currently there is little evidence to support the efficacy of screening for the early detection of these cancers. Another option is risk-reducing hysterectomy and/or bilateral salpingo-oophorectomy (BSO). Research on the impact of BSO in premenopausal women with a non-LS associated family history cancer has generally shown that women have a high level of satisfaction about their decision to undergo surgery. However, debilitating menopausal symptoms and sexual dysfunction are common post-surgical problems. We used a mixed methods study to explore the impact of risk-reducing gynaecological surgery in women with LS: 24 women were invited to take part; 15 (62.5 %) completed validated questionnaires and 12 (50 %) participated in semi-structured interviews. Our results suggest that risk reducing surgery does not lead to significant psychological distress and the women tend not to think or worry much about developing cancer. However, they tend to be distressed about the physical and somatic symptoms associated with menopause; their social well-being is somewhat affected, but sexual difficulties are minimal. The women reported being overwhelmingly satisfied with their decision to have surgery and with the quality of information they received prior to the operation. However, they felt underprepared for menopausal symptoms and received conflicting advice about whether or not to use HRT. Recommendations from the study include that professionals discuss the menopause, its side effects and HRT in detail prior to surgery.

Entities:  

Mesh:

Year:  2015        PMID: 25342222     DOI: 10.1007/s10689-014-9761-0

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  31 in total

1.  Short term psychological distress in patients actively approached for genetic counselling after diagnosis of breast cancer.

Authors:  Kathryn J Schlich-Bakker; Carla C Wárlám-Rodenhuis; Jeanne van Echtelt; Jan van den Bout; Margreet G E M Ausems; Herman F J ten Kroode
Journal:  Eur J Cancer       Date:  2006-09-01       Impact factor: 9.162

2.  The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy.

Authors:  P J C Bresser; C Seynaeve; A R Van Gool; M F Niermeijer; H J Duivenvoorden; S van Dooren; A N van Geel; M B Menke-Pluijmers; J G M Klijn; A Tibben
Journal:  Eur J Cancer       Date:  2006-11-13       Impact factor: 9.162

3.  Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.

Authors:  Amy Østertun Geirdal; Jon G Reichelt; Alv A Dahl; Ketil Heimdal; Lovise Maehle; Astrid Stormorken; Pål Møller
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 4.  New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy.

Authors:  Suzanne M Miller; Pagona Roussi; Mary B Daly; John Scarpato
Journal:  Clin Cancer Res       Date:  2010-09-09       Impact factor: 12.531

5.  A meta-analytic investigation of the relationship between the psychological distress of cancer patients and their carers.

Authors:  L J Hodges; G M Humphris; G Macfarlane
Journal:  Soc Sci Med       Date:  2005-01       Impact factor: 4.634

6.  Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome.

Authors:  Kathleen M Schmeler; Molly S Daniels; Pamela T Soliman; Russell R Broaddus; Michael T Deavers; Thuy M Vu; George J Chang; Karen H Lu
Journal:  Obstet Gynecol       Date:  2010-02       Impact factor: 7.661

7.  High-risk premenopausal women's experiences of undergoing prophylactic oophorectomy: a descriptive study.

Authors:  Nina Hallowell; James Mackay; Martin Richards; Martin Gore; Ian Jacobs
Journal:  Genet Test       Date:  2004

8.  Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene.

Authors:  A Finch; K Metcalfe; J Lui; C Springate; R Demsky; S Armel; B Rosen; J Murphy; L Elit; P Sun; S Narod
Journal:  Clin Genet       Date:  2009-03       Impact factor: 4.438

9.  Psychological side effects of breast cancer screening.

Authors:  C Lerman; B Trock; B K Rimer; C Jepson; D Brody; A Boyce
Journal:  Health Psychol       Date:  1991       Impact factor: 4.267

10.  A menopause-specific quality of life questionnaire: development and psychometric properties.

Authors:  John R Hilditch; Jacqueline Lewis; Alice Peter; Barbara van Maris; Alan Ross; Edmée Franssen; Gordon H Guyatt; Peter G Norton; Earl Dunn
Journal:  Maturitas       Date:  2008 Sep-Oct       Impact factor: 4.342

View more
  6 in total

1.  Distinctive psychological and social experiences of women choosing prophylactic oophorectomy for cancer prevention.

Authors:  Rachel Meadows; Tasleem J Padamsee; Electra D Paskett
Journal:  Health Care Women Int       Date:  2018-02-02

2.  Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models.

Authors:  Yusuke Kobayashi; Hiroyasu Kashima; Ren-Chin Wu; Jin-Gyoung Jung; Jen-Chun Kuan; Jinghua Gu; Jianhua Xuan; Lori Sokoll; Kala Visvanathan; Ie-Ming Shih; Tian-Li Wang
Journal:  Clin Cancer Res       Date:  2015-06-24       Impact factor: 12.531

3.  Quality of life following prophylactic gynecological surgery: experiences of female Lynch mutation carriers.

Authors:  Holly Etchegary; Elizabeth Dicks; Laura Tamutis; Lesa Dawson
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

4.  Pain evaluation during gynaecological surveillance in women with Lynch syndrome.

Authors:  Jorien Helder-Woolderink; Geertruida de Bock; Harry Hollema; Magda van Oven; Marian Mourits
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

Review 5.  The practice of universal screening for Lynch syndrome in newly diagnosed endometrial carcinoma.

Authors:  Aifen Wang; Jenna McCracken; Yanjing Li; Lingfan Xu
Journal:  Health Sci Rep       Date:  2018-06-14

6.  Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals.

Authors:  Nuria Dueñas; Matilde Navarro; Àlex Teulé; Ares Solanes; Mònica Salinas; Sílvia Iglesias; Elisabet Munté; Jordi Ponce; Jordi Guardiola; Esther Kreisler; Elvira Carballas; Marta Cuadrado; Xavier Matias-Guiu; Napoleón de la Ossa; Joan Lop; Conxi Lázaro; Gabriel Capellá; Marta Pineda; Joan Brunet
Journal:  Cancers (Basel)       Date:  2020-11-18       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.